Jamie Dimon Signals Potential Challenges for JPMorgan Bankers Romantic Getaways in US Highlight Travel Industry Trends for 2026 Europe Risks AI Dependency Trap as Tech Dominance Shifts to US and Asia Report Warns AnheuserBusch InBev Shares Dip After Sales Miss Estimates Shells Capital Return Strategy Faces Renewed Market Scrutiny Broadcom Meta Applied Materials Partner on 125M UCLA Semiconductor Hub RDZN Q1 2026 Earnings Significant EPS Miss Highlights Cost Challenges Plains GP Holdings PAGP Q1 2026 Earnings Strong EPS Beat Drives Stock Higher TUYA Q1 2026 Earnings Narrow EPS Miss Leaves Stock Flat Amid Steady Operations EP Q3 2025 Earnings Loss Per Share Reported Amid Ongoing Industry Headwinds REPX Q1 2026 Earnings EPS Falls Sharply Below Estimates Stock Gains on Strategic Optimism MS Q1 2026 Earnings Strong EPS Beat Driven by Wealth Management and Trading MoonLake Immunotherapeutics MLTX Holds Near Support as Biotech Sector Sends Mixed Signals Rithm Capital RITM Holds Steady at 926 as Markets Eye Key Support and Resistance Levels Genenta Science GNTA Surges 69 as Biotechnology Stock Tests Key Resistance Levels XORTX Therapeutics XRTX Gains 127 as Shares Test Key Resistance Level Larimar Therapeutics LRMR Edges Higher as Biotech Stock Hovers Near Key Resistance Metas Two Key Developments Could Stabilize Struggling Stock First Advantage Corporation FA Q1 2026 Earnings EPS Beats Estimates by 216 Despite Stock Decline Anavex Life Sciences AVXL Edges Lower Hovering Near Key Support